ACOUSIA THERAPEUTICS
Acousia Therapeutics GmbH is a privately held biotech company based in Tübingen, Germany. Acousia has experience and expertise in identifying and developing small molecule drug candidates for the treatment of hearing loss. Sensory hair cells are the key cells for hearing in the inner ear. Acousia`s approach will help to replace lost hair cells by cellular regeneration originating from supporting cells. ASpherecousia is developing drugs for local application, which will restore hearing in patients who have lost their hearing ability induced by various reasons, e.g. noise trauma, treatment with ototoxic drugs or sudden deafness. In addition, these therapies will have the potential to treat the age-related decrease in hearing capacity.
ACOUSIA THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2012-01-01
Address:
Tübingen, Baden-Wurttemberg, Germany
Country:
Germany
Website Url:
http://www.acousia.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
12.5 M EUR
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon WordPress Organization Schema Sitelinks Search Box Person Schema Vimeo WP Rocket
Similar Organizations
AMSilk
AMSilk produces and distributes high-quality silk biopolymers.
Cinclus Pharma
Cinclus Pharma is a research based biotech company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Cygnal Therapeutics
Cygnal Therapeutics is a biotechnology company
GetSteps
GetSteps are into custom orthopedic insole market by providing tailored insole.
ImmunOs Therapeutics
ImmunOs Therapeutics is a clinical-stage biotechnology company.
Kamleon
Kamleon is a science-based early-stage company.
ONK Therapeutics
ONK Therapeutics is an innovative cell therapy organisation.
PeproMene Bio
PeproMene Bio is a virtual, privately funded biotech company .
RadioMedix
RadioMedix, Inc. is a privately held biotechnology company
Current Employees Featured
Founder
Investors List
Esperante Ventures
Esperante Ventures investment in Venture Round - Acousia Therapeutics
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund investment in Series B - Acousia Therapeutics
LBBW VC
LBBW VC investment in Series B - Acousia Therapeutics
Creathor Ventures
Creathor Ventures investment in Series B - Acousia Therapeutics
Bregua
Bregua investment in Series B - Acousia Therapeutics
KfW
KfW investment in Series B - Acousia Therapeutics
Axxam
Axxam investment in Series A - Acousia Therapeutics
KfW
KfW investment in Series A - Acousia Therapeutics
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund investment in Series A - Acousia Therapeutics
Official Site Inspections
http://www.acousia.com Semrush global rank: 14.83 M Semrush visits lastest month: 36
- Host name: 185.243.133.181
- IP address: 185.243.133.181
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Acousia Therapeutics"
About › Acousia Therapeutics GmbH
Acousia has several exclusive co-operations with leading institutions in the field of hearing loss research and development. We work closely with UKT Translational Hearing Research Group of Tuebingen University, which is dedicated to both …See details»
Acousia Therapeutics - Crunchbase Company Profile & Funding
Acousia Therapeutics GmbH is a privately held biotech company based in Tübingen, Germany. Acousia has experience and expertise in identifying and developing small molecule drug …See details»
Bimokalner - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 21, 2024 TÜBINGEN, Germany, Aug. 12, 2024 /PRNewswire/ -- Acousia Therapeutics GmbH, a Tübingen-based clinical stage biotech company focused on the enhancement and …See details»
ACOU082 - Drug Targets, Indications, Patents - Synapse - Patsnap
TÜBINGEN, Germany, Nov. 24, 2022 /PRNewswire/ --Acousia Therapeutics GmbH, and its partners from the Translational Hearing Research Group at the Tübingen Hearing Research …See details»
Approach › Acousia Therapeutics GmbH
Geneva: World Health Organization; 2021. Dementia prevention, intervention, ... Acousia develops small molecule drugs, which are designed to affect validated targets expressed in the cochlea. Our unique dual mode of action approach …See details»
Acousia Therapeutics - Crunchbase
Organization. Acousia Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Similar Companies. Edit Similar Companies Section. Acousia Therapeutics, Cygnal …See details»
Acousia Therapeutics - Craft
Acousia Therapeutics is a biotech company working to identify small molecules for treatment of hearing loss. The Company develops a technology which will help to replace lost hair cells by …See details»
Acousia Therapeutics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
Acousia Therapeutics' Clinical Trial to Address Hearing Loss from ...
Oct 9, 2023 Acousia Therapeutics, a clinical-stage biotech company focused on the development of novel drug therapies for the prevention and treatment of acute and chronic …See details»
Acousia Therapeutics (Acousia Therapeutics GmbH) - startbase.com
Recent mentions of Acousia Therapeutics in podcasts & videos: Jobs at Acousia Therapeutics: Other Startups nearby. Invisibel. Startup 2020 Tübingen. Invisibel. Automated helm for …See details»
Acousia Therapeutics (Acousia Therapeutics GmbH) - Startbase
Weitere Startups in der Nähe von Acousia Therapeutics. Invisibel. Startup 2020 Tübingen. Invisibel. Automatisierter Helm für Radfahrer, verpackt in einem Rucksack. BlueLab …See details»
Acousia Therapeutics to present its first-in-class hearing loss ...
May 11, 2022 Acousia is focused on the development of proprietary drug candidates, which are designed to affect the sensory outer hair cells (OHC) in the cochlea of the inner ear. The …See details»
Acousia Therapeutics - Tech Stack, Apps, Patents & Trademarks
Jul 15, 2024 Organization. Acousia Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech …See details»
ACOU085 (bimokalner) in Cisplatin-induced Hearing Loss - ICH GCP
Jul 19, 2024 Acousia Therapeutics GmbH. Investigators. Principal Investigator: Sven Becker, MD, Dept. of Otolaryngology of Tübingen University, Germany Study record dates. These …See details»
Overview: Promising Future Treatments for Tinnitus and Hearing …
Mar 16, 2014 Acousia looks interesting, because Hubert Löwenheim was also the founder of Otogene, a company which was refounded as Sound Pharmaceuticals. He is a well known …See details»
Acousia Therapeutics receives EUR 2.5 million to develop …
Dec 14, 2016 These programs will be further progressed by Acousia to generate clinical candidates to be developed subsequently to demonstrate clinical proof of concept. ... Axxam …See details»
Ecosia - the search engine that plants trees
Ecosia uses 100% of its profits for the planet and produces enough renewable energy to power all searches twice over.See details»
Programs › Acousia Therapeutics GmbH
Acousia develops small molecule drug candidates as a first-line treatment for patients in need of immediate, high, and localized drug exposure to help preserve their hearing. Following the …See details»
News › Acousia Therapeutics GmbH
Aug 12, 2024 Acousia Therapeutics GmbH will be presenting data on the company’s clinical stage, first-in-class lead candidate ACOU085 at the Hanson Wade 2nd Inner Ear Therapeutics …See details»